GB2113091A - Anthelmintics - Google Patents
Anthelmintics Download PDFInfo
- Publication number
- GB2113091A GB2113091A GB08300647A GB8300647A GB2113091A GB 2113091 A GB2113091 A GB 2113091A GB 08300647 A GB08300647 A GB 08300647A GB 8300647 A GB8300647 A GB 8300647A GB 2113091 A GB2113091 A GB 2113091A
- Authority
- GB
- United Kingdom
- Prior art keywords
- active
- formula
- compounds
- group
- substance combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000507 anthelmentic effect Effects 0.000 title claims description 12
- 229940124339 anthelmintic agent Drugs 0.000 title description 3
- 239000000921 anthelmintic agent Substances 0.000 title description 3
- 239000013543 active substance Substances 0.000 claims description 37
- 241001465754 Metazoa Species 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 23
- 241000242711 Fasciola hepatica Species 0.000 claims description 13
- 244000000013 helminth Species 0.000 claims description 9
- 208000006275 fascioliasis Diseases 0.000 claims description 8
- 239000000969 carrier Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 241000242541 Trematoda Species 0.000 claims description 5
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 claims description 5
- 230000003071 parasitic effect Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- HDDSHPAODJUKPD-UHFFFAOYSA-N fenbendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 HDDSHPAODJUKPD-UHFFFAOYSA-N 0.000 claims description 4
- 230000000366 juvenile effect Effects 0.000 claims description 4
- NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 claims description 3
- 241000869417 Trematodes Species 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 1
- 241001494479 Pecora Species 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008187 granular material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 208000015336 Helminthic disease Diseases 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QOUSCKKLBRWNSE-UHFFFAOYSA-N 2-octadecyl-1h-benzimidazole Chemical class C1=CC=C2NC(CCCCCCCCCCCCCCCCCC)=NC2=C1 QOUSCKKLBRWNSE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282985 Cervus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000882760 Fascioloides Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000007931 coated granule Substances 0.000 description 1
- 230000002192 coccidiostatic effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000004491 dispersible concentrate Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960005473 fenbendazole Drugs 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
1
GB 2 113 091 A 1
10
SPECIFICATION Anthelmintics
The present invention relates to novel anthelmintic compositions containing as active component an active substance combination, and to the use of the compositions for controlling helminths, particularly trematodes, both in domestic animals and in productive animals.
The active-substance combinations on which the compositions according to the invention are based have a synergistic activity exceeding in an advantageous manner the additive effect of the individual active substances forming the combination. The active-substance combinations comprise the following individual active substances: a compound of the formula I
(I),
10
wherein n is 0 or 1
and a compound of the formula II
r2—x.
TX>
(II),
H
wherein R, is the group —NH—COO—Ra, in which R3 is an alkyl group having 1 to 9 carbon atoms, 15 preferably methyl, or R, is a thiazol-4-yl group, Rz is an alkyl group having 1 to 4 carbon atoms, 15
preferably n-propyl, phenyl unsubstituted or substituted by halogen or alkyl, or it is a cycloalkyl group having 3 to 6 carbon atoms, and X is 0, S, SO, CO, methylene, preferably S or SO, or an —NH—COO group, including the isomers embraced by the formula II, and also the acid addition salts of these compounds.
20 The compounds described in the foregoing as active substance components of the compositions 20 according to the invention are already known individually as being compounds having anthelmintic activity. Compounds of the formula I are described for example in the German Offenlegungsschrift No. 2,815,621, and those of the formula II in Am. Journ. Vet. Res. 37,1515-16 (1976), in the Belgian Patent Specification No., 793 358, and in Vet. Rec. 101, (9) 260—63,1977.
25 The combination of different chemical compounds to produce a synergistic intensification of 25 activity for controlling pests is gaining to an increasing extent in importance because of the possibility the combination offers for effectively counteracting the ever more frequent appearance of resistance of parasites to individual compounds. Consequently, the normally necessitated increase in the amounts of active substance used to overcome this build-up of resistance of the parasites can largely be avoided. 30 The resulting saving in the amounts of active substance applied has both economical and, by virtue of a 30 lessening of environmental contamination, significant ecological advantages. In the administratin of anthelmintics to productive animals, this can means a reduction in the dose applied, with which is simultaneously associated a lowering of the level of intoxication of the treated animals, with the result that their effective output during the treatment is not impaired.
35 Helminthic diseases among domestic animals and productive animals are widespread. These 35 diseases lead to a reduction in the growth and in the output of the affected animals, and can even result in their death. A particularly dangerous helminthic disease is Fasciolose, which is caused by parasitic liver flukes (for example Fasciola hepatica, Faciola gigantica and Fascioloides spp.) and which occurs especially in ruminants, such as sheep and cattle. The losses attributable to this helminthic disease can 40 assume considerable proportions, particularly when this disease occurs in epidemic form in herds of 40 cattle. The control and prevention of Fasciolose are therefore looked upon as a serious problem urgently requiring a solution in order to avoid such, above all economically grave, losses in animal production. In spite of the numerous known preparations in the field covering the control of helminths, it has hitherto not been possible to develop active substances which, in addition to having good generatl anthelminthic 45 properties, exhibit a satisfactory action against adult and juvenile Fasciola genera in sheep and cattle 45 while simultaneously having low toxicity.
It has now been found that the active-substance combinatins which are contained in the compositions according to the invention, and which comprise a compound of the formula I and compounds of the formula II, display a high level of anthelmintic activity, having not only a wide
GB 2 113 091 A 2
spectrum of activity against nematodes, cestodes and trematodes, but also a very strongly marked action against Fasciola spp. in domestic animals and in productive animals (ruminants and horses). To be emphasised as being particularly advantageous is the fact that the active-substance combinations on which the compositions according to the invention are based have, even in very small doses, a total 5 action against liver flukes in sheep, especially also against juvenile stages, so that side-effects, which 5 could result in an impairment of the development and of the effective output of the treated animals during the period of treatment, are avoided by virtue of small doses.
The action of the active-substance combinations against Fasciola hepatica is significantly above the additive action of the individual compounds forming the combinations.
10 The following combinations are to be regarded as being preferred: 10
A) 5-chloro-6-(2', 3'-dichlorophenoxy)-2-methylthiobenzimidazole either with
B) [5-(propylthio)-1 H-benzimidazole-2-yl]-carbamic acid methyl ester ("Albendazoi"), or with
C) [5-(phenylthio)-1 H-benzimidazole-2-yl]-carbamic acid methyl ester ("Fenbendazoi").
The applicable weight ratios of compounds of the formula I to compounds of the formula II for the 15 active-substance combinations according to the present invention are within the range of 1 : 50 to 15 50 :1. The combination ratio of 1 :10 to 10 :1 is particularly favourable for bringing into effect the synergistic action.
Tests on sheep infested with Fasciola hepatica
36 sheep were artificially infested with metacercaria of Fasciola hepatica. For this purpose, the 20 metacercaria were injected, in an aqueous 0.4% suspension of carboxymerthyl cellulose, directly into 20 the rumen of the test animals. The animals were divided for medication into approximately equally large groups and into three control groups. After four weeks, the active substances were administered to the animals, in doses of 5 to 10 mg/kg of body weight, according to the specified combination. The sheep were kept during the test in paddock boxes under normal conditions. In order to test the action of the 25 individual active-substance combinations, a count was made in the faeces, using a standard technique, 25 12 to 15 weeks after infestation and 8 to 11 weeks after medication, of the eggs deposited by the liver flukes. The test animals Nos. 1—25, not belonging to group B and control group B' (= animals Nos. 26—36), were subsequently killed, and the number of liver flukes present was determined. The results were as follows:
TABLE 1
EPG*
Adult flukes found by autopsy
Substance
Sheep or mixture
14th
15th
mean
%
No.
(dose mg/kg)
week week number value reduction
1
65
125
12
1
60
60
23
89.4
3
A (5.0)
0
5
2
10.2
4
10
0
14
5
0
0
0
6
5
0
4
7
8
A + C (5.0 + 5.0)
0 0
0 0
0 0
1.0
99.0
9
0
0
0
10
0
10
2
11
5
15
2
12
A + B (5.0 + 4.6)
0
0
0
0.8
99.2
13
0
0
0
14
0
0
0
15
40
300
78
\ /
16
700
500
115
\ /
17
untreated
510
620
119
95.8
x
18
control A'
150
230
62
/\
19
920
240
105
/ \
3
GB 2 113 091 A 3
TABLE 2
EPG*
Adult flukes found by autopsy
Sheep
Substance
12th
13th
mean
%
No.
(dose mg/kg)
week week number value reduction
20
54
21
C (5.0)
—
-
77
71
0
22
82
23
untreated
58
\ /
24
control C'
—
—
70
70
25
82
26
360
1110
27
B (4.6)
370
560
_
. -
—* *
28
290
370
29
880
1280
30
710
680
\ /
31
untreated
400
670
\ /
32
control B'
1290
1270
\ /
33
580
660
**"*
—
\/
34
860
850
/\
35
570
410
/ \
36
600
1450
/ \
Key (Tables 1+2)
substance A: 5-chloro-6-(2',3'-dichlorophenoxy)-2-methylthiobenzimidazole,
substance C: [5-(phenylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester ("Fenbendazol"),
substance B: [5-(propylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester ("Albendazol").
EPG*: Number of eggs of liver flukes per gram of faeces (week after carrying out of artificial infestation with metacercaria);
**: It is known from the literature that Albendazol in a comparable dose is ineffective against 6-week-old and younger liver flukes (Austral. Vet. J. 55, 431-432, 1979;
Brit. Vet. J. 138, 371-382, 1982).
Results
The active-substance combinations on which the compositions according to the invention are based exhibited a degree of effectiveness of over 99%, even against juvenile Fasciola hepatica. The 5 action of these combinations is therefore significantly above the additive action of the individual 5
compounds forming the combinations.
After administration of therapeutically effective doses of the active-substance combinations,
clinical tests revealed no toxicity symptoms in the test animals.
The active-substance combinations according to the invention are used to control parasitic 10 helminths in domestic and productive animals, such as cattle, sheep, goats, horses, cats and dogs, and 10 also in the red deer preserves. The combinations can be administered either in single doses to the animals, or in repeated doses, the single doses being, depending on the species of animal, preferably between 0.5 and 100 mg per kg of body weight. A better effect can be obtained in some cases by a protracted administration, or smaller complete doses may suffice. The active substances or the mixtures 15 contasining them can also be added to the feed or be introduced into drinking troughs. The finished feed 15 contains the active-substances combinations preferably at a concentratin of 0.005 to 0.1 per cent by weight. The compositions can be administered to the animals perorally in the form of solutions,
emulsions, suspensions (drenches), powders, tablets, boluses or capsules. These preparations are prepared by the use of example of customary solid carriers, such as kaolin, talcum, bentonite, sodium 20 chloride, calcium phosphate or cottonseed meal, or by the use of liquids that do not react with the 20 active substances, such as oils and other solvents and diluents harmless to the animal organism.
Provided that the physical and toxicological properties of solutions or emulsions permit it, the active-substance combinations can be also injected into the animals subcutaneously, or can be applied by means of the pour-on-method. Furthermore, administration of the active substances to the animals is 25 also possible by means of licking stones (salt) or molasses blocks. 25
4_
5
10
15
20
25
30
35
40
45
GB 2 113 091 A 4
When the anthelmintic compositions are in the form of feed concentrates, the main carriers used are feed materials, such as hay, production feed, fodder grain or protein concentrates. The feed can contain, in addition to the active substances, also additives, vitamins, antibiotics, chemotherapeutical agents, or other pesticides, chiefly bacteriostatics, fungistatics, coccidiostatics, and also hormone preparations, substances having anabolic activity, or other substances promoting growth, affecting the 5 quality of the meat of slaughter cattle, or being in some other way beneficial for the organism. They can also be combined with insecticides and acaricides, by virtue of which the action of the compositions is broadened and adapted to suit the given circumstances.
The anthelmintic compositions according to the invention are produced in a manner known per se by the intimate mixing and grinding of the active-substance combinations, comprising compounds of 10 the formula I and compounds of the formula II, with suitable carriers, optionally with the addition of dispersing agents or solvents which are all inert to the active substances.
The anthelmintic compositions according to the invention can be used for example in the following preparations:
Solid preparations: 1 g granulates (coated granules, impregnated granules and homogeneous granules); water-dispersible concentrates of active substance (wettable powders).
Liquid preparation:
Solutions, pastes, emulsions or dispersions, such as ready-for-use suspensions (drenches).
The particle size of the carriers is advantageously up to about 0.1 mm for dusts and wettable 20 powders, and 0.01—0.5 mm for granulates.
The concentration of the active-substance combinations in the solid preparations may be 0.5 to 80%, and 0.5 to 50% in the liquid preparations.
To these mixtures can also be added additives stabilising the active-substance combinations,
and/or nonionic, anionic and cationic-active substances, which ensure for example better wettability 25 (wetting agents) and dispersibility (dispersing agents).
EXAMPLE
Water-dispersible powder mixture
25 parts by weight of an active-substance combination of compounds of the formula I
with compounds of the formula II are thoroughtly mixed, in a mixer, with 30
7.5 parts by weight of an absorbent carrier, for example silicic acid,
59.4 parts by weight of a carrier, for example bolus alba or kaolin,
0.5 part by weight of oleic acid,
5.3 parts by weight of octylphenylpolyglycol ether, and
2.3 parts by weight of a stearyl-benzimidazole derivative. 35
This mixture is ground in a dowelled disk mill or an air jet mill until the particle size is 5—15 ftm. The wettable powder thus obtained gives a good suspension in water.
1. A synergistic composition for controlling parasic helminths, which composition contains as active component an active-substance combination comprising at least one compound of the formula I 40
Claims (10)
- (I)wherein n is 0 or 1,and at least one compound of the formula II(II)Hwherein R, is the group —NH—COO—R3, in which R3 is an alkyl group having 1 to 9 carbon atoms, 45GB 2 113 091 A 5preferably methyl, or R, is a thiazol-4-yi group, R2 is an alkyl group having 1 to 4 carbon atoms,preferably n-propyl, phenyl unsubstituted or substituted by halogen or alkyl, or it is a cycloalkyl group having 3 to 6 carbon atoms, and X is 0, S, SO, CO, methylene, preferably S or SO, or an —NH—COO group, including the isomers embraced by the formula II, and also the acid addition salts of these 5 compounds, together with suitable carriers and/or distributing agents and diluents. 5
- 2. A composition for controlling parasitic helminths, according to Claim 1, which contains as active component an active-substance combination comprising: 5-chloro-6-(2',3'-dichlorophenoxy)-2-methylthiobenzimidazole and[5-(propylthio)-1H-benzimidazole-2-yl]-carbamic acid methyl ester, together with suitable carriers 10 and/or distributing agents and diluents. 10
- 3. A composition for combating parasitic helminths, according to Claim 1, which contains as active component an active-substance combination comprising: 5-chloro-6-(2',3'-dichlorophenoxy)-2-methyithiobenzimidazole and[5-(phenylthio)-1H-benzimidazole-2-yl]-carbamic acid methyl ester, together with suitable carriers 15 and/or distributing agents and diluents. 15
- 4. An anthelmintic composition according to any of Claims 1 to 3, wherein the weight ratio,in the active-substance combination, of compounds of the formula I to compounds of the formula II is 1 : 50 to 50:1.
- 5. An anthelmintic composiion according to any of Claims 1 to 3, wherein the weight ratio, in the20 active-substance combination, of compounds of the formula I to compounds of the formula II is 1 :10 to 20 10:1.
- 6. A composition according to any of Claims 1 to 5 for the treatment of domestic animals and productive animals.
- 7. A method of controlling parasitic helminths, which method comprises treating the host animal25 with an effective amount of an active-substance combination according to any of Claims 1 to 5. 25
- 8. A method according to Claim 7 wherein the helminths are trematodes.
- 9. A method according to Claim 7 wherein the helminths are liver flukes (Fasciola spp.) in any stages of development.
- 10. A method according to Claim 9 whereby liver flukes are controlled in the juvenile status.Printed for Her Majesty's Stationery Office by the Courier Press, Leamington Spa, 1983. Published by the Patent Office, 25 Southampton Buildings, London, WC2A 1AY, from which copies may be obtained.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH17982 | 1982-01-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8300647D0 GB8300647D0 (en) | 1983-02-09 |
| GB2113091A true GB2113091A (en) | 1983-08-03 |
| GB2113091B GB2113091B (en) | 1985-07-31 |
Family
ID=4181065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08300647A Expired GB2113091B (en) | 1982-01-13 | 1983-01-11 | Anthelmintics |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0084516B1 (en) |
| JP (1) | JPS5936613A (en) |
| AU (1) | AU1031183A (en) |
| BG (1) | BG38936A3 (en) |
| CA (1) | CA1200200A (en) |
| DE (1) | DE3361358D1 (en) |
| DK (1) | DK10583A (en) |
| ES (1) | ES8503199A1 (en) |
| GB (1) | GB2113091B (en) |
| IL (1) | IL67659A (en) |
| MA (1) | MA19678A1 (en) |
| PH (1) | PH19183A (en) |
| ZA (1) | ZA83186B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU658598B2 (en) * | 1991-01-19 | 1995-04-27 | Hoechst Aktiengesellschaft | A pour-on formulation for the administration of anthelmintics |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0705101B1 (en) * | 1993-05-26 | 2001-12-19 | Commonwealth Scientific And Industrial Research Organisation | Antiparasitic compositions |
| AU687062B2 (en) * | 1993-05-26 | 1998-02-19 | Commonwealth Scientific And Industrial Research Organisation | Controlled release antiparasitic compositions |
| EP0710105B1 (en) * | 1993-06-15 | 2003-07-30 | The Australian National University | Synergistic anthelmintic compositions against fasciola hepatica and other fasciola species |
| AU679753B2 (en) * | 1993-06-15 | 1997-07-10 | Australian National University, The | Synergistic anthelmintic compositions |
| AUPQ770200A0 (en) * | 2000-05-23 | 2000-06-15 | Commonwealth Scientific And Industrial Research Organisation | Tablets for animals |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4197307A (en) * | 1977-04-12 | 1980-04-08 | Ciba-Geigy Corporation | 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents |
| JPS57139012A (en) * | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
-
1983
- 1983-01-03 MA MA19895A patent/MA19678A1/en unknown
- 1983-01-07 DE DE8383810006T patent/DE3361358D1/en not_active Expired
- 1983-01-07 EP EP83810006A patent/EP0084516B1/en not_active Expired
- 1983-01-10 PH PH28368A patent/PH19183A/en unknown
- 1983-01-11 CA CA000419253A patent/CA1200200A/en not_active Expired
- 1983-01-11 GB GB08300647A patent/GB2113091B/en not_active Expired
- 1983-01-11 IL IL67659A patent/IL67659A/en unknown
- 1983-01-12 AU AU10311/83A patent/AU1031183A/en not_active Abandoned
- 1983-01-12 BG BG059320A patent/BG38936A3/en unknown
- 1983-01-12 DK DK10583A patent/DK10583A/en not_active Application Discontinuation
- 1983-01-12 ZA ZA83186A patent/ZA83186B/en unknown
- 1983-01-12 ES ES518931A patent/ES8503199A1/en not_active Expired
- 1983-01-13 JP JP58002934A patent/JPS5936613A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU658598B2 (en) * | 1991-01-19 | 1995-04-27 | Hoechst Aktiengesellschaft | A pour-on formulation for the administration of anthelmintics |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA83186B (en) | 1983-10-26 |
| IL67659A (en) | 1985-07-31 |
| DK10583D0 (en) | 1983-01-12 |
| DK10583A (en) | 1983-07-14 |
| ES518931A0 (en) | 1985-02-16 |
| JPS5936613A (en) | 1984-02-28 |
| PH19183A (en) | 1986-01-23 |
| GB2113091B (en) | 1985-07-31 |
| GB8300647D0 (en) | 1983-02-09 |
| EP0084516A1 (en) | 1983-07-27 |
| EP0084516B1 (en) | 1985-12-04 |
| BG38936A3 (en) | 1986-03-14 |
| MA19678A1 (en) | 1983-10-01 |
| CA1200200A (en) | 1986-02-04 |
| DE3361358D1 (en) | 1986-01-16 |
| ES8503199A1 (en) | 1985-02-16 |
| AU1031183A (en) | 1983-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1200200A (en) | Anthelmintics | |
| US3558778A (en) | Methods and compositions for use in animal husbandry | |
| US4166865A (en) | Macrotetrolide animal growth promotor | |
| NZ205238A (en) | Synergistic mixtures as anthelmintic | |
| EP0125004B1 (en) | Synergistic antiparasitic compositions | |
| US4436737A (en) | Anthelmintic compositions | |
| US3958008A (en) | Anthelmintic methods of use | |
| US4659713A (en) | Quinoxalinedione compounds useful for controlling coccidiosis | |
| CA1217430A (en) | Anthelmintics | |
| US2628183A (en) | Composition for control of coccidial infection | |
| US4034110A (en) | Anthelmintics effective against liver flukes | |
| IE832793L (en) | Synergistic anthelmintic composition. | |
| US3968209A (en) | Anthelmintic use of phosphorylated thioureas | |
| JPH07173055A (en) | Anticoccidial composition | |
| US4462995A (en) | Pyridyl phosphorothioate compositions and their use as anabolic agents | |
| US4042703A (en) | Method of treating and preventing coccidiosis | |
| EP1210950B1 (en) | Composition against Coccidiosis | |
| EP0160115B1 (en) | Growth stimulating food additive for animals | |
| FI79644B (en) | SYNERGISTIC TILLVAEXTBEFODRANDE FODERTILLSATSAEMNE FOER BOSKAP. | |
| US3457351A (en) | Anthelmintic compositions and methods employing 2 - (2' - oxazolin-2'-yl)-benzimidazoles | |
| US3592894A (en) | Treatment of intestinal helminthiasis with tetrachlorofulvenes | |
| US3484519A (en) | Anthelmintic 2-substituted benzimidazole-metal arsenate compositions and method | |
| CA1123455A (en) | 2,4-dichloro-n-(chloro-(2,4- dichloropheyl)methylene)benzenecarbohydrazonyl chloride, method of making and method of controlling manure breeding insects | |
| US3167474A (en) | Composition for combatting coccidiosis and method of using same | |
| CA1211643A (en) | Synergic growth-promoting feed supplement composition for farm animals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |